Bruner JM - Search Results

1

Risk assessment for developing gliomas: a comparison of two cytogenetic approaches.

El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q. El-Zein R, et al. Among authors: bruner jm. Mutat Res. 2001 Jan 25;490(1):35-44. doi: 10.1016/s1383-5718(00)00154-6. Mutat Res. 2001. PMID: 11152970

2

Mutagen sensitivity and risk of gliomas: a case-control analysis.

Bondy ML, Kyritsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, Bruner JM, Wei Q. Bondy ML, et al. Among authors: bruner jm. Cancer Res. 1996 Apr 1;56(7):1484-6. Cancer Res. 1996. PMID: 8603389

3

Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas.

El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q. El-Zein R, et al. Among authors: bruner jm. Carcinogenesis. 1999 May;20(5):811-5. doi: 10.1093/carcin/20.5.811. Carcinogenesis. 1999. PMID: 10334198

4

Gamma-radiation sensitivity and risk of glioma.

Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q. Bondy ML, et al. Among authors: bruner jm. J Natl Cancer Inst. 2001 Oct 17;93(20):1553-7. doi: 10.1093/jnci/93.20.1553. J Natl Cancer Inst. 2001. PMID: 11604478

5

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW. Levin VA, et al. Among authors: bruner jm. Clin Cancer Res. 2003 Mar;9(3):981-90. Clin Cancer Res. 2003. PMID: 12631596 Clinical Trial.

6

The treatment of anaplastic oligodendrogliomas and mixed gliomas.

Kyritsis AP, Yung WK, Bruner J, Gleason MJ, Levin VA. Kyritsis AP, et al. Neurosurgery. 1993 Mar;32(3):365-70; discussion 371. doi: 10.1227/00006123-199303000-00005. Neurosurgery. 1993. PMID: 8455760

7

Mutations of the p16 gene in gliomas.

Kyritsis AP, Zhang B, Zhang W, Xiao M, Takeshima H, Bondy ML, Cunningham JE, Levin VA, Bruner J. Kyritsis AP, et al. Oncogene. 1996 Jan 4;12(1):63-7. Oncogene. 1996. PMID: 8552400

8

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.

Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH. Levin VA, et al. Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):58-66. doi: 10.1016/s0360-3016(01)02819-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12007942 Clinical Trial.

9

Correlation of p53 immunoreactivity and sequencing in patients with glioma.

Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM. Kyritsis AP, et al. Among authors: bruner jm. Mol Carcinog. 1996 Jan;15(1):1-4. doi: 10.1002/(SICI)1098-2744(199601)15:1<1::AID-MC1>3.0.CO;2-O. Mol Carcinog. 1996. PMID: 8561860

10

Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.

Fueyo J, Gomez-Manzano C, Bruner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WK, Kyritsis AP. Fueyo J, et al. Among authors: bruner jm. Oncogene. 1996 Oct 17;13(8):1615-9. Oncogene. 1996. PMID: 8895506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters